News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
With the California licensure, the company’s PCR-based Colvera colorectal cancer monitoring test is available in all US states except New York.
The funding totals up to $5.6 million over five years and will incorporate Talis' proprietary SlipChip technology.
The firm said that the decline was due to a customer shifting to internalizing genetic ordering, adverse weather, and the loss of an undisclosed commercial payor.
Researchers from Stanford University reported in a pilot study that seven RNA transcripts could predict preterm birth.
The collaboration will make use of Fluidigm's automated microfluidic systems to accelerate the design of panels for translational and clinical researchers.
